These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 39162873)
21. Effect of loureirin A against Candida albicans biofilms. Lin MY; Yuan ZL; Hu DD; Hu GH; Zhang RL; Zhong H; Yan L; Jiang YY; Su J; Wang Y Chin J Nat Med; 2019 Aug; 17(8):616-623. PubMed ID: 31472899 [TBL] [Abstract][Full Text] [Related]
22. Antibiofilm and Antivirulence Activities of 6-Gingerol and 6-Shogaol Against Lee JH; Kim YG; Choi P; Ham J; Park JG; Lee J Front Cell Infect Microbiol; 2018; 8():299. PubMed ID: 30211127 [No Abstract] [Full Text] [Related]
23. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against Raut JS; Bansode BS; Jadhav AK; Karuppayil SM J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin. Messier C; Epifano F; Genovese S; Grenier D Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508 [TBL] [Abstract][Full Text] [Related]
25. Repurposing of respiratory drug theophylline against Candida albicans: mechanistic insights unveil alterations in membrane properties and metabolic fitness. Singh S; Fatima Z; Ahmad K; Hameed S J Appl Microbiol; 2020 Oct; 129(4):860-875. PubMed ID: 32320111 [TBL] [Abstract][Full Text] [Related]
26. 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans. Subramenium GA; Swetha TK; Iyer PM; Balamurugan K; Pandian SK Microbiol Res; 2018 Mar; 207():19-32. PubMed ID: 29458854 [TBL] [Abstract][Full Text] [Related]
27. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis. Zhu C; Liao B; Ye X; Zhou Y; Chen X; Liao M; Cheng L; Zhou X; Ren B Int J Antimicrob Agents; 2021 Sep; 58(3):106394. PubMed ID: 34197906 [TBL] [Abstract][Full Text] [Related]
28. Mitigating candidiasis with acarbose by targeting Candida albicans α-glucosidase: in-silico, in-vitro and transcriptomic approaches. David H; Vasudevan S; Solomon AP Sci Rep; 2024 May; 14(1):11890. PubMed ID: 38789465 [TBL] [Abstract][Full Text] [Related]
29. Antifungal, anti-biofilm, and anti-hyphal properties of Shaik S; Lee JH; Kim YG; Lee J Front Cell Infect Microbiol; 2024; 14():1414618. PubMed ID: 38903941 [No Abstract] [Full Text] [Related]
30. Liu RH; Shang ZC; Li TX; Yang MH; Kong LY Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584159 [TBL] [Abstract][Full Text] [Related]
31. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis. Rossoni RD; de Barros PP; de Alvarenga JA; Ribeiro FC; Velloso MDS; Fuchs BB; Mylonakis E; Jorge AOC; Junqueira JC Biofouling; 2018 Feb; 34(2):212-225. PubMed ID: 29380647 [TBL] [Abstract][Full Text] [Related]
32. Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans. Haghdoost NS; Salehi TZ; Khosravi A; Sharifzadeh A J Mycol Med; 2016 Dec; 26(4):298-305. PubMed ID: 27789229 [TBL] [Abstract][Full Text] [Related]
33. Development of Lee HS; Kim Y J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739 [No Abstract] [Full Text] [Related]
34. Antibiofilm activity of selected plant essential oils from the Proškovcová M; Čonková E; Váczi P; Harčárová M; Malinovská Z Ann Agric Environ Med; 2021 Jun; 28(2):260-266. PubMed ID: 34184508 [TBL] [Abstract][Full Text] [Related]
35. β-citronellol alters cell surface properties of Candida albicans to influence pathogenicity related traits. Sharma Y; Rastogi SK; Perwez A; Rizvi MA; Manzoor N Med Mycol; 2020 Jan; 58(1):93-106. PubMed ID: 30843057 [TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model. El-Azizi M; Farag N; Khardori N Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806 [TBL] [Abstract][Full Text] [Related]
37. Phloretin inhibited the pathogenicity and virulence factors against Liu N; Zhang N; Zhang S; Zhang L; Liu Q Bioengineered; 2021 Dec; 12(1):2420-2431. PubMed ID: 34167447 [TBL] [Abstract][Full Text] [Related]
38. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Messier C; Grenier D Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543 [TBL] [Abstract][Full Text] [Related]
39. Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Manoharan RK; Lee JH; Kim YG; Lee J Front Cell Infect Microbiol; 2017; 7():447. PubMed ID: 29085811 [No Abstract] [Full Text] [Related]
40. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Gao M; Wang H; Zhu L Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]